Page last updated: 2024-08-18

cyclohexanol and Anochlesia

cyclohexanol has been researched along with Anochlesia in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (25.00)18.2507
2000's7 (43.75)29.6817
2010's4 (25.00)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Cinar, R; Gao, B; Godlewski, G; Gunduz-Cinar, O; Herrerias, A; Iyer, MR; Kunos, G; Lin, Y; Santos-Molina, L; Wood, CM; Zawatsky, CN1
Ardashov, O; Ivanova, Е; Kapitsa, I; Khazanov, V; Salakhutdinov, N; Valdman, E; Volcho, K; Voronina, TI1
Abdelrahman, M; Gamage, TF; Greig, IR; Ignatowska-Jankowska, BM; Lichtman, AH; Pertwee, RG; Poklis, J; Ross, RA; Thakur, GA; Tichkule, R; Trembleau, L; Wiley, JL1
Grim, TW; Lichtman, AH; Morales, AJ; Negus, SS; Wiebelhaus, JM1
Bosier, B; Hermans, E; Lambert, DM; Michotte, Y; Sarre, S; Smolders, I1
Boulet, JM; Chaffer, SM; Elsemore, DA; Gottshall, SL; Harrison, JE; Koetzner, L; Lee, G; Mark, L; Miller, W; Pearson, MS; Rabadi, L; Rotshteyn, Y; Shan, S; Tafesse, L; Toth, M; Turchin, PI; Valenzano, KJ; Whiteside, GT1
Brain, C; Chen, A; Courade, JP; Dyson, A; Fox, A; Groarke, A; Loong, Y; Peacock, M; Yaqoob, M1
Antoniou, K; Daifoti, Z; Galanopoulos, A; Kourouli, T; Marselos, M; Nahmias, V; Panagis, G; Papahatjis, D; Spyraki, C; Thermos, K; Vlachou, S1
Andersson, M; Borgkvist, A; Borrelli, E; Dominguez, C; Fienberg, AA; Fisone, G; Fredholm, BB; Greengard, P; Pozzi, L; Svenningsson, P; Usiello, A1
Giridharagopalan, S; Hamamoto, DT; Simone, DA1
Dai, D; Duncan, SG; Huffman, JW; Jordan, RD; Lainton, JA1
Anderson, JJ; Chase, TN; Kask, AM1
Balster, RL; Compton, DR; Dutta, A; Gordon, PM; Lichtman, AH; Martin, BR; Razdan, RK; Siegel, C; Singer, M; Wiley, JL1
Bonner, T; Buckley, NE; Felder, CC; Glass, M; McCoy, KL; Mezey, E; Zimmer, A1
Arnold, JC; Hunt, GE; Mallet, PE; McGregor, IS; Topple, AN1
Banijamali, A; Charalambous, A; Compton, DR; Friend, FL; Lin, S; Makriyannis, A; Marciniak, G; Martin, BR1

Other Studies

16 other study(ies) available for cyclohexanol and Anochlesia

ArticleYear
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
    Molecules (Basel, Switzerland), 2021, Aug-22, Volume: 26, Issue:16

    Topics: Alcohol Drinking; Animals; Anxiety; Behavior, Animal; Cannabinoid Receptor Antagonists; Catalepsy; Cyclohexanols; Elevated Plus Maze Test; Endotoxemia; Endotoxins; Ethanol; Gastrointestinal Tract; Hypothermia, Induced; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stereoisomerism; Sulfonamides

2021
Evolution of anti-parkinsonian activity of monoterpenoid (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in various in vivo models.
    European journal of pharmacology, 2017, Nov-15, Volume: 815

    Topics: Animals; Antiparkinson Agents; Catalepsy; Cyclohexanols; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Oxotremorine; Parkinsonian Disorders; Reserpine

2017
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
    Behavioural pharmacology, 2014, Volume: 25, Issue:2

    Topics: Allosteric Regulation; Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catalepsy; Cyclohexanols; Dronabinol; Drug Evaluation; Eating; Endocannabinoids; Female; Hypothermia; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Nociception; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2014
Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice.
    Drug and alcohol dependence, 2015, May-01, Volume: 150

    Topics: Animals; Brain; Catalepsy; Conditioning, Operant; Cyclohexanols; Dose-Response Relationship, Drug; Drug Tolerance; Male; Medial Forebrain Bundle; Mice; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward; Rimonabant; Self Stimulation

2015
Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.
    Neuropharmacology, 2010, Volume: 59, Issue:6

    Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoids; Catalepsy; Cyclohexanols; Dronabinol; Male; Motor Activity; Rats; Rats, Wistar; Time Factors

2010
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
    Neuropharmacology, 2005, Volume: 48, Issue:5

    Topics: Amines; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anxiety; Ataxia; Behavior, Animal; Benzoxazines; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Immunosuppressive Agents; Indoles; Indomethacin; Inflammation; Male; Mice; Mice, Knockout; Morpholines; Naphthalenes; Pain; Pain Measurement; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB2; Time Factors

2005
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
    Pain, 2005, Volume: 116, Issue:1-2

    Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Catalepsy; Cell Line; Chromatography; Cricetinae; Cricetulus; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Freund's Adjuvant; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypothermia; Inflammation; Ligation; Male; Morpholines; Motor Activity; Naphthalenes; Pain; Pain Measurement; Pain Threshold; Radioligand Assay; Rats; Rats, Wistar; Rotarod Performance Test; Sciatic Neuropathy; Sulfur Isotopes; Time Factors; Tritium

2005
Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane delta8-THC analog, AMG-3.
    Behavioural pharmacology, 2005, Volume: 16, Issue:5-6

    Topics: Animals; Behavior, Animal; Binding, Competitive; Cannabinoids; Catalepsy; Cell Membrane; Cerebral Cortex; Cyclohexanols; Dose-Response Relationship, Drug; Male; Molecular Structure; Motor Activity; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Time Factors; Tritium

2005
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Sep-14, Volume: 25, Issue:37

    Topics: Animals; Cannabinoids; Catalepsy; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Cyclohexanols; Dopamine and cAMP-Regulated Phosphoprotein 32; Mice; Mice, Inbred C57BL; Neurons; Phosphorylation; Protein Subunits; Receptor, Cannabinoid, CB1

2005
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
    European journal of pharmacology, 2007, Mar-08, Volume: 558, Issue:1-3

    Topics: Animals; Apomorphine; Benzoxazines; Cannabinoid Receptor Agonists; Catalepsy; Cyclohexanes; Cyclohexanols; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Morpholines; Naphthalenes; Phenols; Receptors, Cannabinoid; Sarcoma, Experimental

2007
Variation of the alkyl side chain in delta 8-THC.
    Life sciences, 1995, Volume: 56, Issue:23-24

    Topics: Analgesics; Animals; Binding, Competitive; Catalepsy; Cyclohexanols; Dronabinol; Hypothermia; Mice; Motor Activity; Structure-Activity Relationship

1995
Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.
    European journal of pharmacology, 1996, Jan-11, Volume: 295, Issue:2-3

    Topics: Animals; Benzazepines; Brain; Catalepsy; Cyclohexanols; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Piperidines; Pyrazoles; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Salicylamides

1996
Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
    Neuropharmacology, 1996, Volume: 35, Issue:12

    Topics: Animals; Body Temperature Regulation; Cannabinoids; Catalepsy; Cyclohexanols; Dronabinol; Male; Maze Learning; Mice; Mice, Inbred ICR; Motor Activity; Nitrogen Mustard Compounds; Pain; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship

1996
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
    European journal of pharmacology, 2000, May-19, Volume: 396, Issue:2-3

    Topics: Animals; Body Temperature; Catalepsy; Cyclohexanols; Dronabinol; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cannabinoid; Receptors, Drug; T-Lymphocytes

2000
The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.
    Brain research, 2001, Dec-07, Volume: 921, Issue:1-2

    Topics: Analgesics; Animals; Behavior, Animal; Body Temperature; Brain; Cannabinoids; Catalepsy; Cell Count; Cyclohexanols; Dose-Response Relationship, Drug; Immunohistochemistry; Marijuana Abuse; Motor Activity; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Lew; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug

2001
Pharmacological evaluation of halogenated delta 8-THC analogs.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:3

    Topics: Analgesics; Animals; Binding, Competitive; Body Temperature; Catalepsy; Cyclohexanols; Dronabinol; Male; Mice; Mice, Inbred ICR; Motor Activity; Receptors, Cannabinoid; Receptors, Drug

1991